Abstract. In the present study, two isostructural lanthanide (Ln) (III) complexes, namely Ln(HL) 2 (NO 3 )(CH 3 OH) 2 )·CH 3 OH, where Ln = La in complex 1 and Ce in complex 2, and hydrogen ligand (HL) = (E)-N'-[1-(2-pyridinyl)ethylidene]isonicotinohydrazone, have been isolated and characterized by elemental analysis, infrared spectra and single-crystal X-ray diffraction analysis. The results revealed that the acylhydrazone ligand HL in each complex was deprotonated as an anionic ligand and coordinated to the central La(III) ion via enolization of oxygen and nitrogen atoms. Furthermore, the antitumor effects and potential mechanisms of the two complexes were explored in the human lung cancer cell line A549 and in the human gastric cancer cell lines BGC823 and SGC7901. In the present study, the roles the two complexes on the proliferation and apoptosis of the above tumor cell lines were determined by MTT assay and Annexin V/propidium iodide flow cytometry, respectively. Furthermore, various apoptosis-associated key genes, including caspase 3, B cell lymphoma (Bcl)-2-associated X protein (Bax) and Bcl-2, were detected by western blotting to explore the possible antitumor mechanisms of the two complexes. The results revealed that the two complexes had comparable antitumor activities in terms of inhibiting proliferation and inducing apoptosis in tumor cell lines. The changes in the protein expression levels of caspase 3, Bax and Bcl-2 further verified the apoptosis-promoting mechanisms of the two complexes in tumor cell lines. These findings have a great potential in biomedical applications of novel Ln(III) complexes.
Introduction
It is well known that Schiff bases are important in the development of coordination chemistry due to their ease of synthesis and structural tenability, and their ability to form a wide variety of complexes of chemical, biological and industrial importance (1) (2) (3) (4) (5) . Aroyl hydrazones are members of the Schiff bases family, which are built with aromatic acid hydrazides (aroyl hydrazides) and carbonyl compounds (1) . Hydrazone complexes have been studied for numerous years due to their antimicrobial and antitumor activities (6) (7) (8) (9) (10) (11) . Hydrazone ligands can offer a combination of amide oxygen and imine nitrogen as donor atoms, with the imine nitrogen being involved in the formation of an N-N bond reminiscent of a doubly reduced azo functionality. Due to the short N-N bond length, the hydrazone ligands act mostly as tridentate moieties, although they have the potential to behave as bridging tetradentate ligands (12) .
The chemistry of the trivalent lanthanide (Ln) ions has attracted significant attention in the last 40 years (13) (14) (15) . In addition to their magnetic and photophysical properties, the bioactivities of Lns, including their antimicrobial, antitumor, antivirus and anticoagulant action, as well as their ability to prevent arteriosclerosis, have been explored in recent decades (16) (17) (18) (19) .
The present study synthesized the hydrogen ligand (HL) (E)-N'-[1-(2-pyridinyl)ethylidene]isonicotinohydrazone and prepared its two Ln(III) complexes. Furthermore, the antitumor effects and potential mechanisms of the two Ln(III) complexes with HL were explored in the human lung cancer cell line A549 and in the human gastric cancer cell lines BGC823 and SGC7901.
Materials and methods

Materials and measurements.
All starting materials were obtained commercially and used as received. All the rear earth salts were purchased from Beijing Chemical Works (Beijing, China). The A549 human lung cancer, and the BGC823 and SGC7901 human gastric cancer cell lines, were obtained from the Cell Culture Center of the Basic Institute of Medical Sciences, Peking Union Medical College (Beijing, China). Cell culture reagents were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). MTT and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Polyvinylidene fluoride (PVDF) membranes and non-fat dry milk were obtained from EMD Millipore (Billerica, MA, USA).
The elemental analyses were performed in the microanalytical laboratory of the Department of Chemistry, Lanzhou University (Lanzhou, China). The infrared (IR) spectra (KBr pellet) were recorded using an FTS 165 Fourier transform (FT)-IR spectrophotometer (Bio-Rad Laboratories, Inc., Hercules, CA, USA) in the range of 4,000-400 cm -1 . Cell lines were cultured in an incubator (Thermo Fisher Scientific, Inc.) under the condition of 100% humidity, 5% CO 2 at 37˚C. RPMI-1640 culture medium was purchased from HycClone (GE Healthcare Life Sciences, Chalfont, UK). CKX51 microscope (Olympus Corporation, Tokyo, Japan) and ToupCam FMA050 (ToupTek Photonics, Hangzhou, China) were used to obtain images of the cells. The MTT assay was performed using a microplate reader (Infinite F50; Tecan Schweiz AG, Männedorf, Switzerland). The flow cytometer Accuri C6 was purchased from BD Biosciences (Franklin Lakes, NJ, USA).
Preparations of the ligand and complexes. The ligand HL was prepared as described previously (20) . In brief, HL was obtained by condensation of 2-acetylpyridine (0.1 mmol) and isonicotinohydrazone (0.1 mmol) in ethanol solution with the addition of 0.1 ml concentrated acetic acid. The parameters of the IR spectrum of HL were as follows: IR (KBr) cm -1 : ν(NH), 3, 194 ; ν(C=O), 1,679; and ν(C=N), 1,586. Complex 1 was prepared as follows: Ce(NO 3 ) 3 ·6H 2 O (217.1 mg, 0.5 mmol; Beijing Chemical Works) in ethanol (20 ml) was added to a solution containing the ligand HL (240 mg, 1 mmol) in methanol (10 ml) with 0.05 ml triethylamine. The mixture was stirred for 12 h at 25˚C to allow the formation of the precipitate of the Ce(III) complex. The precipitate was separated by centrifugation at 2,000 x g for 10 min at 25˚C, and washed three times with ethanol and one time with ether, and finally dried in vacuo. Slow evaporation of the mixed methanol/ ethanol solution containing Ce(III) complex 1 led to a yellow single crystal that was suitable for X-ray diffraction (XRD). The calculated parameters for C 29 H 34 CeN 9 O 8 were as follows: : ν(NH), 3,081; ν(C=O), 1,578; and ν(C=N), 1,518. The complexes are soluble at room temperature in ethanol, methanol, dimethylformamide and DMSO.
X-ray crystallography. The XRD measurements for the two complexes were performed on a SMART APEX II CCD diffractometer (Bruker Corporation, Billerica, MA, USA) equipped with a graphite monochromatized Mo-Ka radiation (λ=0.071073 nm) by using φ-ω scan mode. Mo-Ka radiation is the standard operation used in structure elucidation, where Mo-Ka indicates the molybdenum-kalium target radiography and λ is the X-Ray diffraction wavelength. Semi-empirical absorption correction was applied to the intensity data using the SADABS program version 2.03 (Bruker Corporation) (21) . The structures were solved by direct methods and refined by full matrix least-square on F 2 using the SHELXTL version 97 program (Bruker Corporation) (22) . The non-hydrogen atoms of the disordered methanol solvent molecules were refined isotropically. However, the H atoms on the solvent molecules were not added, and were directly included in the molecular formula. The other non-hydrogen atoms were refined anisotropically. H atoms for coordinated solvent molecules were located from difference Fourier maps and refined with restraints in bond length and thermal parameters. All the other H atoms were positioned geometrically and refined using a riding model. Details of the crystal parameters, data collection and refinements for complexes 1 and 2 are summarized in Table I . The selected bond lengths and angles are listed in Tables II and III, respectively. Cytotoxic activity assay. The effects of the DMSO-soluble HL and the complexes 1 and 2 on the proliferation of the human lung cancer cell line A549 and the human gastric cancer lines BGC823 and SGC7901 were explored by MTT assay. The half maximal inhibitory concentration (IC 50 ) was further calculated according to the results of the MTT assay. Briefly, the three types of tumor cell lines evaluated in the present study were plated in 96-well plates in triplicate and grown to 75% confluence. Following treatment with different concentrations of the complexes 1 and 2 for 72 h, the media were replaced with 10 µl of fresh medium containing 0.45 mg/ml MTT reagent. The cells were incubated for 1 h at 37˚C in the presence of 5% CO 2 to allow the formation of formazan crystals. The formazan crystals were dissolved by addition of 100 µl DMSO during a 4-h incubation period at 37˚C and 5% CO 2 . The colorimetric change was measured on a spectrophotometer at an absorbance wavelength of 570 nm. Data were expressed as the percentage of viability relative to vehicle. At least three independent experiments were performed.
Flow cytometry analysis. Apoptotic rates were determined by flow cytometry using the FITC Annexin V Apoptosis Detection kit I, which contains propidum iodide (PI) for red fluorescence detection (cat. no. 556547; BD Biosciences). Briefly, the cancer cells (A549) were seeded at a density of 1x10 6 cells/well in 6-well plates overnight, and then treated with 5, 10 and 15 µmol/l complex 2 for 48 h. Cells (1x10 6 ) were collected by centrifugation 200 x g for 5 min at 4˚C and washed twice with cold PBS. Staining was performed according to the manufacturer's protocol, and the cells were analyzed using a flow cytometer (Accuri C6; BD Biosciences) with 488 nm excitation wavelength and 530 nm emission wavelength. The green fluorescence of Annexin V and the red fluorescence of PI was detected by flow cytometry. The results were analyzed using Cell Quest software version 6.0 (BD Biosciences). At least three independent experiments were performed.
Western blotting. The aforementioned three types of tumor cells were seeded in 6-well plates overnight. Cells were treated with 5 µmol/l complex 2 for 48 h. Upon treatment, all the cell samples were washed twice with PBS and lysed in RIPA Lysis Buffer (cat. no. P0013C; Beyotime Institute of Biotechnology, Haimen, China). The protein concentration of each sample was determined with a bicinchoninic acid assay kit (cat. no. P0009; Beyotime Institute of Biotechnology). The The numbers between parentheses indicate the standard deviation to the third decimal place.
samples were separated by 12% SDS-PAGE, transferred to PVDF membranes by electroblotting and blocked using 5% dried skimmed milk overnight at 4˚C. Next, the membranes were probed with polyclonal antibodies against caspase 3 (1:1,000; cat. no. 3004; BioVision, Inc., Milpitas, CA, USA), the apoptosis regulators B cell lymphoma (Bcl)-2-associated X protein (Bax) (1:1,000; cat. no. 3032; BioVision, Inc.) and 
The numbers between parentheses indicate the standard deviation to the third decimal place.
Bcl-2 Statistical analysis. All data were analyzed by SAS 6.12 software, and the results were expressed as the mean + standard deviation. To compare the differences between the groups, the statistical significance was analyzed using a one-way analysis of variance followed by post hoc comparisons. P<0.05 was considered to indicate a statistically significant difference.
Results and Discussion
Crystal structures of complexes 1 and 2. As revealed by single-crystal XRD, complexes 1 and 2 are isostructural and crystallize in the monoclinic Pn space group (Table I) . The structure of complex 1 will be discussed in detail as a representative example. As shown in Fig. 1A , once coordinated with a metal ion, the acylhydrazone ligand is deprotonated and acts as tridentate mono-basic ligand. The 10-coordinated La(III) ion with bicapped square antiprism coordination geometry (Fig. 1B) is surrounded by two L (Fig. 1C) . This is similar in the crystal structure of complex 2, with D···A distances of 0.272(5) and 0.2719(9) nm, and D-H···A angles of 142.1 and 165.9˚, respectively.
IR spectra. The solid-state FT-IR spectra of the complexes, recorded on a FT-IR spectrophotometer in the range 4,000-200 cm -1 , were fully consistent with their single crystal structures. The samples were studied as powder dispersed in KBr pellets. The spectral region for all the complexes was somewhat similar due to the similarity in the coordination modes of the ligands with the metal centre. The ν(C=O) of the free ligand is 1,679 cm -1 , while for complexes 1 and 2, this peak shifted to 1,586 and 1,578 cm -1 , respectively. In addition, the ν(ligand-complexes) is ~100 cm -1 , thus indicating that the O atom of the C=O bond participates in the coordination to the metal ion. The stretching frequency of the azomethine (CH=N) group in the hydrazone ligand was observed to be ~1,586 cm -1 , which shifted to lower frequency values upon complexation with the metal by 70 cm -1 , indicating that the N atom of the C=N bond participates in the coordination to the metal ion. The vibrations ν(N-H) disappear in the spectra of the two complexes, indicating that the ligand is deprotonated. The new bands at ~550 cm -1 for complexes 1 and 2 are Table IV . IC 50 (µmol/l) values of the ligand and complexes 1 and 2 against the human lung cancer A549 and the human gastric cancer BGC823 and SGC7901 cell lines after incubation for 72 h. Antitumor activities. It has been reported that arylhydrazone and their metal complexes display particularly effective antitumor activities, possibly due to their NO bidentate systems (23) . In consequence, in vitro cytotoxicity assays were explored in the human lung cancer cell line A549 and in the human gastric cancer cell lines BGC823 and SGC7901. The two metal complexes displayed a concentration-dependent cytotoxic profile in all cell lines, and their IC 50 values are shown in Table IV . The IC 50 values of complexes 1 and 2 were significantly lower than that of the metal-free ligand in all the tested cell lines, which suggested that the coordinated Ln(Ⅲ) ion served a major role in mediating the potency of the complexes. Morphological examinations also revealed that the proliferation of the cells was significantly inhibited, and that the cells exhibited morphological changes such as cell shrinkage and detachment (Fig. 2) .
Cell apoptosis. MTT assay demonstrated that complexes 1 and 2 exhibited growth inhibition abilities on the three human cancer cell lines evaluated, and that complex 2 exhibited relatively better cytotoxic activities than complex 1 on the human lung cancer cell line A549. For this reason, complex 2 and the human lung cancer cell line A549 were employed in the subsequent apoptosis and western blot analyses. To determine whether the proliferation inhibition induced by complex 2 on A549 cells was attributed to the induction of apoptosis, Annexin V/PI staining and flow cytometry were applied to quantify the percentage of apoptosis. As shown in Fig. 3 , the number of apoptotic A549 cells increased in a dose-dependent manner following incubation with 5, 10 and 15 µmol/l complex 2 for 48 h (P<0.05).
Caspase 3, Bax and Bcl-2 protein expression. As previously reported, caspase 3 and Bcl-2 family proteins are key regulators of the apoptotic pathway. When caspase 3 and Bax expression is high, the cells proceed into apoptosis, while when Bcl-2 is produced in excess, cells are protected from apoptosis (24, 25) . In the present study, western blotting was applied to detect the protein expression of caspase 3, Bax and Bcl-2 in the human lung cancer cell line A549 treated with different concentrations of complex 2 for 48 h. The results revealed that caspase 3 and Bax protein expression significantly increased, while Bcl-2 protein expression was remarkably downregulated upon incubation with 5 µmol/l complex 2 for 48 h (Fig. 4) . These results suggested that the possible mechanism of complex 2 responsible for its ability to induce A549 cell apoptosis may be associated with its ability to increase the expression of caspase 3 and Bax, and to decrease the expression of Bcl-2. These results may improve the understanding of the pharmacological mechanisms of novel Ln(III) complexes in cancer treatment.
In summary, two isostructural Ln(III) complexes with isonicotinohydrazone ligand have been isolated and characterized by elemental analyses, IR spectra and single-crystal XRD analyses in the present study. The results indicate that the two complexes exert considerable cytotoxic activity against three cancer cell lines (human lung cancer cell line A549, and human gastric cancer cell lines BGC823 and SGC7901), and that the IC 50 values of complexes 1 and 2 are lower than that of the ligand. Annexin V/PI staining and western blotting further suggested that Ln(III) complexes can induce apoptosis in A549 cells. Those findings may potentially be useful for biomedical applications of novel Ln(III) complexes, particularly in the human cancer therapeutic field. 
